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Therenaladenomascanbeconfusedbyimagingdiagnosiswithmalignantrenaltumors,buttherearealsorealbiologicaldilemmas
to determine their behavior. The consensus decisions are the following. (1) The adenoma of clear cells is not accepted, instead it is
considered that all the clear-cell tumors are carcinomas, with greater or lesser aggressiveness. (2) Among the papillary neoplasms
the WHO 2004 renal cell tumors classiﬁcation are considered as papillary adenomas tumors with a maximum diameter of 5mm
and may represent a continuum biological process to papillary renal cell carcinoma. The papillary adenomas associated with
End-kidney and/or acquired cystic disease may have a diﬀerent pathogenesis. (3) To consider a tumor as an oncocytoma the
size is not important, only the cytological features, microscopic, ultrastructural, and immunohistochemically can help, but some
chromosomal observations introduce some questions about its relation with the chromophobe renal cell carcinoma. (4) Finally,
the metanephric adenoma, a tumor with some morphological similarity with the nephroblastoma must be considered in the renal
adenomas diagnosis.
Copyright © 2008 F. Algaba. This is an open access article distributed under the Creative Commons Attribution License, which
permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
1. INTRODUCTION
Beforesonographicstudies,85%to90%ofrenalmasseswere
malignant, with the majority being renal-cell carcinoma.
However, with the increasing frequency of incidentally
discovered renal masses, only 70% to 85% of lesions are
found to be malignant [1].
When we take on the subject of benign neoplasias of
the kidney, we must make two large groups, the benign
mesenchymal neoplasias and the benign epithelial neoplasias
or adenomas.
The benign mesenchymal tumors, with the exception of
the angiomyolypoma, are usually subclinical and rarely give
the pathologist diagnostic problems, although they can be
confused with malignant neoplasias for imaging diagnosis
[2].
The adenomas are a true clinical-pathological dilemma,
not only because they can be confused by imaging diagnosis,
but because there are biological dilemmas to determine and
therefore diﬀerent questions emerge: ﬁrstly, do the renal
adenomas really exist?, and secondly, in case they do exist,
are they precursor lesions of renal carcinomas?, and if they
were, do we have the possibility of diﬀerentiating the benign
neoplasias from the malignant ones?
The current classiﬁcations of renal carcinomas have
managed to integrate the genetic and molecular ﬁndings
with the cytological characteristics [3]. This conjunction has
made it possible to correlate the histological subtypes with
the prognostic and therapeutic ones. For this reason, we can
approach the renal adenomas according they are of clear
cells, of eosinophilic cells (oncocytes), with papillary growth,
or have a metanephric blastema appearance.
2. RESULTS
2.1. Adenomaswithclearcells?
Themostfrequentrenalneoplasiaoftheadultistheclearcell
renal cell carcinoma. When the pieces from the nephrectomy
are studied with this type of carcinoma, around 10% of
the cases are multifocal and small tumor nodes with clear
cells can be found. This same ﬁnding can be made more
frequently in kidneys of patients with von Hipel-Lindau
disease. These nodes could have been considered adenomas
of clear cells, but since Bell’s descriptions [4] it is well known2 Advances in Urology
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Figure 1: Cystic nephroma: cystic neoplasm with ﬁbrous stroma
an ﬂat epithelium covering the wall.
that some of the small clear-cell tumors have metastasis
capacity and therefore currently the existence of an adenoma
of clear cells is not accepted, instead it is considered that all
the clear-cell tumors are carcinomas, with greater or lesser
aggressiveness.
Having established this axiomatic attitude, there is
no problem of diﬀerential diagnosis; however, from the
morphological point of view, the cystic nephroma (Figure 1),
formed by multiple separate cysts (which are also known
as multilocular cyst) covered by epithelium without nuclear
atypia, monolayer, with eosinophilic cytoplasma, can occa-
sionally be covered by cells of clear cytoplasma, without
nuclear atypia. In this case, clear cells must not be found in
the walls and the intercystic stroma. The cystic nephroma
does not have any relation to the multilocular clear cell
carcinoma (despite certain similarity with it) [5]. Currently,
it is being related to other benign neoplasias such as the
mixed epithelial and stromal tumor of the kidney, all of them
a r em u c hm o r ef r e q u e n ti nw o m e na n dw i t he s t r o g e na n d
progesterone receptors in the stromal component [6].
2.2. Papillaryadenomas
In about 35% of the cases the renal carcinomas with a
papillary pattern have multiple lesions of diverse sizes (from
millimeters to centimeters), especially those associated with
family syndromes. This fact again poses the existence of
adenomas and their possible relation with carcinomas.
The small papillary tumors are characterized by a
growth of cells with scant cytoplasma (chromophilic cells),
occasionally somewhat eosinophilic, with tubular-papillary
patterns, well delimited and not encapsulated (Figure 2).
In chromosomal studies, trisomies in chromosomes 7 and
17 were conﬁrmed in the small tumors. Additionally, other
chromosomes presented tri-tetrasomies when the in size of
the tumor increase. From these ﬁndings it was considered
that there is a series of small benign lesions and that the
increase in size is associated with greater amount of chromo-
somal alterations and therefore the possible transformation
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Figure 2: Papillary adenomas: diﬀerent types of basophilic cell
adenomas.
in papillary carcinomas. For this reason, the WHO 2004
renal cell tumors classiﬁcation considered tumors with a
maximum diameter of 5mm as papillary adenomas [3].
In a practical manner, many pathologists consider that the
tumorsover5mmandupto10mmareoflowaggressiveness
[7].
It should be underscored that although the majority of
the papillary adenomas are associated with papillary renal
cell carcinoma (47%), they can also be found associated
with other variants (16% with clear cell RCC, 8% with
chromophobe RCC and 2.5% with oncocytoma) [8].
It should be highlighted that 5% of the papillary
adenomas are found in sclerosed kidneys (end-kidneys) and
18% in patients with acquired cystic disease (with or without
dialysis). Their morphological characteristics are identical to
those associated with carcinomas but curiously they diﬀer
from the latter by not expressing alpha-methylacyl-CoA
racemase (AMACR) [8].
In conclusion, papillary adenoma and papillary renal
cell carcinoma may represent a continuum of the same
biological process. Unfortunately, it is not possible to deﬁne
an unequivocally benign papillary renal adenoma, for this
reason the WHO used the size (arbitrarily) as a marker.
The papillary adenomas associated with end-kidney
and/or acquired cystic disease may have a diﬀerent patho-
genesis.
2.3. Oncocytoma
The clinically most important renal cortical adenoma is the
oncocytoma, since despite the fact that it is not usually
associated with the carcinoma, in the imaging diagnosis it
is usually considered as renal cell carcinoma.
The cytological characteristics of the oncocytoma are
deﬁned by the oncocytic cells (tumor cells arranged in
nests, cords, or tubules, with eosinophilic cytoplasm and
no mitosis). They are usually solid, homogeneous, withF. Algaba 3
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Figure 3: (a) Oncocitomas, (b) eosinophilic chromophobe renal
cell carcinoma variant. Notice the similar aspect that both lesions
can present.
occasional sclerosed central areas, which can also present in
other tumors, and are of a diameter from millimeters up to
12–15 or more centimeters. Therefore, in this tumor type,
the criterion of size does not exist [9].
The problem originates in the cytological characteristics
thatattimesar ediﬃculttodistinguishfromotherneoplasias
of eosinophilic cells, such as the clear-cell renal carcino-
mas eosinophilic variant and especially the chromophobe
eosinophilic carcinomas (Figure 3).
To distinguish them, the electronic microscope, histo-
chemistry (colloidal iron), and immunohistochemistry can
help (Figure 4).
It is interesting to point out that the chromosomal
studies have demonstrated diﬀerent types of alterations, and
therefore while some tumors do not have any chromosomal
alteration, others show translocation 11q13 and (−)1 p ,
14q, Y [10]. The latter chromosomal alteration is similar
to that of the chromophobe carcinomas (−1p, Y), which
together with the ﬁnding of hybrid carcinomas (oncocytoma
+ chromophobe renal cell carcinoma) especially in the Birt-
Hogg-Dub´ e syndrome [11]it has suggestedthatcertaincases
of oncocytomas could evolve into chromophobe renal cell
carcinoma.
2.4. Metanephricadenoma
A relatively short time ago a tumor was introduced among
the renal adenomas that was comprised by small cells with
scant cytoplasma, uniform, without mitosis, embryonic-
appearing,distributedinsmallroundaciniwithaphenotype
similar to the nephroblastoma (Figure 5). They represent 1%
of localized tumors of less than 7cm. The mean age is 41
years (from 5 to 83 years). Fifty percent are incidental and
10% havea polycythemia. Immunohistochemistry, the WT1,
CD 56, and CD 57 are positive and the AMACR is negative
[12].
From the genetic point of view, it is characterized by
allelic loss in 2p13 (56% of the cases) and is diﬀerentiated
from the nephroblastoma (with alterations 11p13) and from
the papillary carcinoma (+7, +17) [13].
Oncocytoma
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Figure 4: Colloidal iron to distinguish oncocytoma (negative) and
chromophobe renal cell carcinoma (positive).
Figure 5: Metanephric adenoma. microacinar structures of
basophilic cells with a nephroblastic appearance.
To distinguish the metanephric adenoma from the
nephroblastoma, strict diagnostic criteria have been used,
and only accepting the tumors without mitosis and nucleoli
as metanephric adenoma.
3. CONCLUSIONS
We see that the criteria used to consider renal neoplasia as
adenoma vary a great deal according to the cellular type
(never in the neoformations of clear cells, only in small
neoplasias of papillary pattern, and any size if we are sure
that they are oncocytic or metanephric cells). Therefore, it is
fundamental to establish the cellular type, and this determi-
nationisusuallydonewiththeusualpathologicalanatomical
methods with the help of the immunohistochemical markers
to which occasionally molecular methods can be added.
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